Short-and long-term effects of wholegrain oat intake on weight management and glucolipid metabolism in overweight type-2 diabetics: A randomized control trial

Nutrients

Volumn 8, Issue 9, 2016, Pages

  Li, Xue ^a,b   Cai, Xiaxia ^a,c   Ma, Xiaotao ^a,d   Jing, Lulu ^a   Gu, Jiaojiao ^a   Bao, Lei ^a,e   Li, Jun ^f   Xu, Meihong ^a   Zhang, Zhaofeng ^a   Li, Yong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d PEKING UNIVERSITY   (China)

^e PEKING UNIVERSITY INTERNATIONAL HOSPITAL   (China)

^f The 153 Central Hospital of Chinese PLA   (China)

Author keywords

Fiber; Oats; Obesity; Type 2 diabetes; Whole grain

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY FAT; BODY WEIGHT MANAGEMENT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET THERAPY; DISEASE DURATION; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OAT; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SMOKING; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; WEIGHT REDUCTION; WHOLE GRAIN; ADMINISTRATION AND DOSAGE; AVENA; BLOOD; DIETARY FIBER; HEALTHY DIET; LOW FAT DIET; METABOLISM; POSTPRANDIAL STATE; TIME FACTOR;

AVENA; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIET, FAT-RESTRICTED; DIETARY FIBER; FEMALE; FOLLOW-UP STUDIES; HEALTHY DIET; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; POSTPRANDIAL PERIOD; TIME FACTORS; TRIGLYCERIDES; WHOLE GRAINS;

EID: 84987752579     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8090549     Document Type: Article

References (36)

1. Series, W.T. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ. Tech. Rep. Ser. 2000, 894, 1–253.
2. NCD Risk Factor Collaboration. Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol. 2015, 3, 624–637.
3. Yaturu, S. Obesity and type 2 diabetes. J. Diabetes Mellit. 2011, 1, 79–95. [CrossRef]
4. Mokdad, A.H.; Ford, E.S.; Bowman, B.A.; Nelson, D.E.; Engelgau, M.M.; Vinicor, F.; Marks, J.S. Diabetes trends in the U.S.: 1990–1998. Diabetes Care 2000, 23, 1278–1283. [CrossRef] [PubMed]
5. American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin. Diabetes 2015, 33, 97–111.
6. American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002, 25, 202–212.
7. Fung, T.T.; Hu, F.B.; Pereira, M.A.; Liu, S.; Stampfer, M.J.; Colditz, G.A.; Willett, W.C. Whole-grain intake and the risk of type 2 diabetes: A prospective study in men. Am. J. Clin. Nutr. 2002, 76, 535–540. [PubMed]
8. Brennan, C.S.; Cleary, L.J. The potential use of cereal (1→3,1→4)-β-D-glucans as functional food ingredients. J. Cereal Sci. 2005, 42, 1–13. [CrossRef]
9. Clemens, R.; van Klinken, B.J. Oats, more than just a whole grain: An introduction. Br. J. Nutr. 2014, 112 (Suppl. S2), S1–S3. [CrossRef] [PubMed]
10. Whitehead, A.; Beck, E.J.; Tosh, S.; Wolever, T.M. Cholesterol-lowering effects of oat beta-glucan: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2014, 100, 1413–1421. [CrossRef] [PubMed]
11. Bao, L.; Cai, X.; Xu, M.; Li, Y. Effect of oat intake on glycaemic control and insulin sensitivity: A meta-analysis of randomised controlled trials. Br. J. Nutr. 2014, 112, 457–466. [CrossRef] [PubMed]
12. Saltzman, E.; Das, S.K.; Lichtenstein, A.H.; Dallal, G.E.; Corrales, A.; Schaefer, E.J.; Greenberg, A.S.; Roberts, S.B. An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women. J. Nutr. 2001, 131, 1465–1470. [PubMed]
13. Othman, R.A.; Moghadasian M.H.; Jones, P.J. Cholesterol-lowering effects of oat beta-glucan. Nutr. Rev. 2011, 69, 299–309. [CrossRef] [PubMed]
14. Shen, X.L.; Zhao, T.; Zhou, Y.; Shi, X.; Zou, Y.; Zhao, G. Effect of oat beta-glucan intake on glycaemic control and insulin sensitivity of diabetic patients: A meta-analysis of randomized controlled trials. Nutrients 2016, 8, 39. [CrossRef] [PubMed]
15. Institute of Nutrition and Food Safety. China CDC 2005 China Food Composition; Peking University Medical Press: Beijing, China, 2005.
16. Chinese Nutrition Society. Dietary Guidelines for Chinese Residents; Tibet People’s Publishing House: Lhasa, China, 2010.
17. Chinese Diabetes Society. China Medical Nutrition Therapy Guideline for Diabetes. Available online: http://www.cdschina.org/news_show.jsp?id=509.html (accessed on 16 October 2012).
18. Sun, Z. Process for Dehulling Oats without Removing Plumules. CN101264459 17 September 2008.
19. Hlebowicz, J. Postprandial blood glucose response in relation to gastric emptying and satiety in healthy subjects. Appetite 2009, 53, 249–252. [CrossRef] [PubMed]
20. Wang, Q.; Ellis, P.R. Oat beta-glucan: Physico-chemical characteristics in relation to its blood-glucose and cholesterol-lowering properties. Br. J. Nutr. 2014, 112 (Suppl. S2), S4–S13. [CrossRef] [PubMed]
21. Pick, M.E.; Hawrysh, Z.J.; Gee, M.I.; Toth, E.; Garg, M.L.; Hardin, R.T. Oat bran concentrate bread products improve long-term control of diabetes: A pilot study. J. Am. Diet. Assoc. 1996, 96, 1254–1261. [CrossRef]
22. Shen, R.L.; Cai, F.L.; Dong, J.L.; Hu, X.Z. Hypoglycemic effects and biochemical mechanisms of oat products on streptozotocin-induced diabetic mice. J. Agric. Food Chem. 2011, 59, 8895–8900. [CrossRef] [PubMed]
23. Schuster, J.; Beninca, G.; Vitorazzi, R.; Morelo Dal Bosco, S. Effects of oats on lipid profile, insulin resistance and weight loss. Nutr. Hosp. 2015, 32, 2111–2116. [PubMed]
24. Qatanani, M.; Lazar, M.A. Mechanisms of obesity-associated insulin resistance: Many choices on the menu. Genes Dev. 2007, 21, 1443–1455. [CrossRef] [PubMed]
25. Charlton, K.E.; Tapsell, L.C.; Batterham, M.J.; O’Shea, J.; Thorne, R.; Beck, E.; Tosh, S.M. Effect of 6 weeks’ consumption of beta-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults. Br. J. Nutr. 2012, 107, 1037–1047. [CrossRef] [PubMed]
26. Ma, X.; Gu, J.; Zhang, Z.; Jing, L.; Xu, M.; Dai, X.; Jiang, Y.; Li, Y.; Bao, L.; Cai, X. et al. Effects of avena nuda l. On metabolic control and cardiovascular disease risk among Chinese patients with diabetes and meeting metabolic syndrome criteria: Secondary analysis of a randomized clinical trial. Eur. J. Clin. Nutr. 2013, 67, 1291–1297. [CrossRef] [PubMed]
27. Torronen, R.; Kansanen, L.; Uusitupa, M.; Hanninen, O.; Myllymaki, O.; Harkonen, H.; Malkki, Y. Effects of an oat bran concentrate on serum lipids in free-living men with mild to moderate hypercholesterolaemia. Eur. J. Clin. Nutr. 1992, 46, 621–627. [PubMed]
28. Kerckhoffs, D.A.; Hornstra, G.; Mensink, R.P. Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies. Am. J. Clin. Nutr. 2003, 78, 221–227. [PubMed]
29. Lyly, M.; Liukkonen, K.H.; Salmenkallio-Marttila, M.; Karhunen, L.; Poutanen, K.; Lahteenmaki, L. Fibre in beverages can enhance perceived satiety. Eur. J. Nutr. 2009, 48, 251–258. [CrossRef] [PubMed]
30. Rose, D.J. Impact of whole grains on the gut microbiota: The next frontier for oats? Br. J. Nutr. 2014, 112 (Suppl. S2), S44–S49. [CrossRef] [PubMed]
31. Viscidi, K.A.; Dougherty, M.P.; Briggs, J.; Camire, M.E. Complex phenolic compounds reduce lipid oxidation in extruded oat cereals. Food Sci. Technol. 2004, 37, 789–796. [CrossRef]
32. El Khoury, D.; Cuda, C.; Luhovyy, B.L.; Anderson, G.H. Beta glucan: Health benefits in obesity and metabolic syndrome. J. Nutr. Metab. 2012, 2012, 851362. [CrossRef] [PubMed]
33. Den Besten, G.; van Eunen, K.; Groen, A.K.; Venema, K.; Reijngoud, D.J.; Bakker, B.M. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 2013, 54, 2325–2340. [CrossRef] [PubMed]
34. Ross, A.B.; Pere-Trepat, E.; Montoliu, I.; Martin, F.P.; Collino, S.; Moco, S.; Godin, J.P.; Cleroux, M.; Guy, P.A.; Breton, I. et al. A whole-grain-rich diet reduces urinary excretion of markers of protein catabolism and gut microbiota metabolism in healthy men after one week. J. Nutr. 2013, 143, 766–773. [CrossRef] [PubMed]
35. Martinez, I.; Lattimer, J.M.; Hubach, K.L.; Case, J.A.; Yang, J.; Weber, C.G.; Louk, J.A.; Rose, D.J.; Kyureghian, G.; Peterson, D.A. et al. Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J. 2013, 7, 269–280. [CrossRef] [PubMed]
36. De Vos, W.M.; de Vos, E.A. Role of the intestinal microbiome in health and disease: From correlation to causation. Nutr. Rev. 2012, 70 (Suppl. S1), S45–S56. [CrossRef] [PubMed]